Friend turned foe: TREM2 agonist in battles against tau

J Exp Med. 2023 Jan 2;220(1):e20221850. doi: 10.1084/jem.20221850. Epub 2022 Nov 18.

Abstract

In this important study, Jain et al. (2022. J. Exp. Med.https://doi.org/10.1084/jem.20220654) find that chronic TREM2 activation by AL002a antibody exacerbates the seeding and spread of pathological tau, enhances the disease-associated microglial signature, and increases neurite dystrophy in 5xFAD mice seeded with Alzheimer's disease tau.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Alzheimer Disease* / pathology
  • Animals
  • Friends
  • Graft vs Host Disease* / pathology
  • Humans
  • Membrane Glycoproteins
  • Mice
  • Microglia / pathology
  • Receptors, Immunologic

Substances

  • TREM2 protein, human
  • Membrane Glycoproteins
  • Receptors, Immunologic
  • Trem2 protein, mouse